Literature DB >> 19858416

Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice.

Daqing Zhang1, Xiaohua Jiang, Pu Fang, Yan Yan, Jian Song, Sapna Gupta, Andrew I Schafer, William Durante, Warren D Kruger, Xiaofeng Yang, Hong Wang.   

Abstract

BACKGROUND: Hyperhomocysteinemia (HHcy) is an independent risk factor for cardiovascular disease. Monocytes display inflammatory and resident subsets and commit to specific functions in atherogenesis. In this study, we examined the hypothesis that HHcy modulates monocyte heterogeneity and leads to atherosclerosis. METHODS AND
RESULTS: We established a novel atherosclerosis-susceptible mouse model with both severe HHcy and hypercholesterolemia in which the mouse cystathionine beta-synthase (CBS) and apolipoprotein E (apoE) genes are deficient and an inducible human CBS transgene is introduced to circumvent the neonatal lethality of the CBS deficiency (Tg-hCBS apoE(-/-) Cbs(-/-) mice). Severe HHcy accelerated atherosclerosis and inflammatory monocyte/macrophage accumulation in lesions and increased plasma tumor necrosis factor-alpha and monocyte chemoattractant protein-1 levels in Tg-hCBS apoE(-/-) Cbs(-/-) mice fed a high-fat diet. Furthermore, we characterized monocyte heterogeneity in Tg-hCBS apoE(-/-) Cbs(-/-) mice and another severe HHcy mouse model (Tg-S466L Cbs(-/-)) with a disease-relevant mutation (Tg-S466L) that lacks hyperlipidemia. HHcy increased monocyte population and selective expansion of inflammatory Ly-6C(hi) and Ly-6C(mid) monocyte subsets in blood, spleen, and bone marrow of Tg-S466L Cbs(-/-) and Tg-hCBS apoE(-/-) Cbs(-/-) mice. These changes were exacerbated in Tg-S466L Cbs(-/-) mice with aging. Addition of l-homocysteine (100 to 500 micromol/L), but not l-cysteine, maintained the Ly-6C(hi) subset and induced the Ly-6C(mid) subset in cultured mouse primary splenocytes. Homocysteine-induced differentiation of the Ly-6C(mid) subset was prevented by catalase plus superoxide dismutase and the NAD(P)H oxidase inhibitor apocynin.
CONCLUSIONS: HHcy promotes differentiation of inflammatory monocyte subsets and their accumulation in atherosclerotic lesions via NAD(P)H oxidase-mediated oxidant stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19858416      PMCID: PMC2783582          DOI: 10.1161/CIRCULATIONAHA.109.866889

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  27 in total

1.  Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata.

Authors:  Filip K Swirski; Peter Libby; Elena Aikawa; Pilar Alcaide; F William Luscinskas; Ralph Weissleder; Mikael J Pittet
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition.

Authors:  Hong Wang; XiaoHua Jiang; Fan Yang; Gary B Chapman; William Durante; Nicholas E S Sibinga; Andrew I Schafer
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

3.  Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.

Authors:  Dan Liao; Hongmei Tan; Rutai Hui; Zhaohui Li; Xiaohua Jiang; John Gaubatz; Fan Yang; William Durante; Lawrence Chan; Andrew I Schafer; Henry J Pownall; Xiaofeng Yang; Hong Wang
Journal:  Circ Res       Date:  2006-08-24       Impact factor: 17.367

4.  Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease.

Authors:  R Poddar; N Sivasubramanian; P M DiBello; K Robinson; D W Jacobsen
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

5.  Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants.

Authors:  M Gaustadnes; N Rüdiger; K Rasmussen; J Ingerslev
Journal:  Thromb Haemost       Date:  2000-04       Impact factor: 5.249

6.  Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia.

Authors:  Sapna Gupta; Jirko Kühnisch; Aladdin Mustafa; Sarka Lhotak; Alexander Schlachterman; Michael J Slifker; Andres Klein-Szanto; Katherine A High; Richard C Austin; Warren D Kruger
Journal:  FASEB J       Date:  2008-11-05       Impact factor: 5.191

7.  Regulatory role of thioredoxin in homocysteine-induced monocyte chemoattractant protein-1 secretion in monocytes/macrophages.

Authors:  Jing Dai; Xiaofei Wang; Juan Feng; Wei Kong; Qingbo Xu; Xun Shen; Xian Wang
Journal:  FEBS Lett       Date:  2008-10-29       Impact factor: 4.124

8.  Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene.

Authors:  M D S Jamaluddin; Irene Chen; Fan Yang; Xiaohua Jiang; Michael Jan; Xiaoming Liu; Andrew I Schafer; William Durante; Xiaofeng Yang; Hong Wang
Journal:  Blood       Date:  2007-08-13       Impact factor: 22.113

9.  Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation.

Authors:  Hong Wang; XiaoHua Jiang; Fan Yang; John W Gaubatz; Lang Ma; Mark J Magera; XiaoFeng Yang; Peter B Berger; William Durante; Henry J Pownall; Andrew I Schafer
Journal:  Blood       Date:  2002-12-27       Impact factor: 22.113

10.  Cystathionine beta-synthase p.S466L mutation causes hyperhomocysteinemia in mice.

Authors:  Sapna Gupta; Liqun Wang; Xiang Hua; Jakub Krijt; Viktor Kozich; Warren D Kruger
Journal:  Hum Mutat       Date:  2008-08       Impact factor: 4.878

View more
  69 in total

Review 1.  Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research.

Authors:  Richard S Beard; Shawn E Bearden
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-22       Impact factor: 4.733

Review 2.  Mitochondrial ROS, uncoupled from ATP synthesis, determine endothelial activation for both physiological recruitment of patrolling cells and pathological recruitment of inflammatory cells.

Authors:  Xinyuan Li; Pu Fang; William Y Yang; Kylie Chan; Muriel Lavallee; Keman Xu; Tracy Gao; Hong Wang; Xiaofeng Yang
Journal:  Can J Physiol Pharmacol       Date:  2016-11-05       Impact factor: 2.273

3.  Inhibition of Caspase-1 Activation in Endothelial Cells Improves Angiogenesis: A NOVEL THERAPEUTIC POTENTIAL FOR ISCHEMIA.

Authors:  Jahaira Lopez-Pastrana; Lucas M Ferrer; Ya-Feng Li; Xinyu Xiong; Hang Xi; Ramon Cueto; Jun Nelson; Xiaojin Sha; Xinyuan Li; Ann L Cannella; Princess I Imoukhuede; Xuebin Qin; Eric T Choi; Hong Wang; Xiao-Feng Yang
Journal:  J Biol Chem       Date:  2015-06-02       Impact factor: 5.157

4.  Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice.

Authors:  Daqing Zhang; Pu Fang; Xiaohua Jiang; Jun Nelson; Jodene K Moore; Warren D Kruger; Remus M Berretta; Steven R Houser; Xiaofeng Yang; Hong Wang
Journal:  Circ Res       Date:  2012-05-24       Impact factor: 17.367

5.  Vein graft disease in a knockout mouse model of hyperhomocysteinaemia.

Authors:  Christina Maria Steger; Tobias Mayr; Nikolaos Bonaros; Johannes Bonatti; Thomas Schachner
Journal:  Int J Exp Pathol       Date:  2016-12-22       Impact factor: 1.925

6.  MicroRNA-155 Deficiency Leads to Decreased Atherosclerosis, Increased White Adipose Tissue Obesity, and Non-alcoholic Fatty Liver Disease: A NOVEL MOUSE MODEL OF OBESITY PARADOX.

Authors:  Anthony Virtue; Candice Johnson; Jahaira Lopez-Pastraña; Ying Shao; Hangfei Fu; Xinyuan Li; Ya-Feng Li; Ying Yin; Jietang Mai; Victor Rizzo; Michael Tordoff; Zsolt Bagi; Huimin Shan; Xiaohua Jiang; Hong Wang; Xiao-Feng Yang
Journal:  J Biol Chem       Date:  2016-11-17       Impact factor: 5.157

7.  DNA methylation profiling reveals differences in the 3 human monocyte subsets and identifies uremia to induce DNA methylation changes during differentiation.

Authors:  Adam M Zawada; Jenny S Schneider; Anne I Michel; Kyrill S Rogacev; Björn Hummel; Nicolas Krezdorn; Soeren Müller; Björn Rotter; Peter Winter; Rima Obeid; Jürgen Geisel; Danilo Fliser; Gunnar H Heine
Journal:  Epigenetics       Date:  2016-03-28       Impact factor: 4.528

Review 8.  Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets.

Authors:  Yi Fu; Xian Wang; Wei Kong
Journal:  Br J Pharmacol       Date:  2017-09-22       Impact factor: 8.739

9.  Metabolic Diseases Downregulate the Majority of Histone Modification Enzymes, Making a Few Upregulated Enzymes Novel Therapeutic Targets--"Sand Out and Gold Stays".

Authors:  Ying Shao; Valeria Chernaya; Candice Johnson; William Y Yang; Ramon Cueto; Xiaojin Sha; Yi Zhang; Xuebin Qin; Jianxin Sun; Eric T Choi; Hong Wang; Xiao-feng Yang
Journal:  J Cardiovasc Transl Res       Date:  2016-01-08       Impact factor: 4.132

10.  Interleukin-17A Promotes Aortic Endothelial Cell Activation via Transcriptionally and Post-translationally Activating p38 Mitogen-activated Protein Kinase (MAPK) Pathway.

Authors:  Jietang Mai; Gayani Nanayakkara; Jahaira Lopez-Pastrana; Xinyuan Li; Ya-Feng Li; Xin Wang; Ai Song; Anthony Virtue; Ying Shao; Huimin Shan; Fang Liu; Michael V Autieri; Satya P Kunapuli; Yoichiro Iwakura; Xiaohua Jiang; Hong Wang; Xiao-Feng Yang
Journal:  J Biol Chem       Date:  2016-01-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.